The European Commission has published a Restrictions Roadmap under REACH, describing this as “an important step forward to provide detailed information on all ongoing work on future restrictions under the EU chemical legislation”.
The European Commission has revised certain information requirements for registering chemicals under REACH. It advised companies to start preparing as the changes will start to apply in October. Further advice will be issued in 2H and changes will be made accordingly in Iuclid.
The main changes concern requirements and specific rules for the adaptation of:
* In vitro and in vivo studies, when further studies are needed based on mutagenicity concerns
CEFIC has released the first in a series of studies about the likely impact of the EU Chemicals Strategy for Sustainability (CSS). It subsequently joined other industry leaders in calling on European Commission and EU Member State governments “to work together to develop an EU Chemical Industry Transition Pathway to sustain the massive investments required to meet the objectives of the EU Green Deal”.
Bachem, the world’s largest peptides manufacturer, has announced some results of two studies it carried out with Novo Nordisk, seeking to make solid-phase peptide synthesis (SPPS) greener.
SPPS requires large volumes of solvents and the current gold standards, because of their excellent solubilisation and stability properties for reagents and resin swelling capabilities, are N-dimethylformamide (DMF), dichloromethane and N-methyl-2-pyrrolidone. All now face restrictions under REACH because of their hazardous nature.
ECHA has prioritised seven substances of very high concern (SVHCs) from the Candidate List and recommended that the European Commission add them to Authorisation List under REACH. All were chosen because they are hazardous, produced in high volumes and widely used, the agency said. This is the tenth such recommendation.
Among them are three siloxanes, which are produced at volumes of up to 1,000 or up to 10,000 tonnes/year. All are deemed to be harmful for the environment because they are persistent, bioaccumulative and toxic and/or very persistent and very bioaccumulative:
Harry Swan, CEO of Thomas Swan, describes the company’s approach to navigating the new post-Brexit rules and offers advice to other firms
Thomas Swan is an independent, family-run chemicals manufacturer that is based in County Durham, UK. I am the great-grandson of the founder and became CEO in 2006. The company dates back to 1926, so you might expect it to be experienced in handling change. Adapting to the UK’s new free trade deal with the EU is another challenge we have met head-on and we are confident of competing successfully in a global market.
In a letter to government ministers that has been seen by the Financial Times, 25 industry leaders have called for “a more proportionate, effective and efficient” post-Brexit chemical regulatory regime in the UK. The writers are understood to be from multiple trade associations, including the Chemical Industries Association (CIA), though this has not been confirmed.